Mehra and Subramanian discussed preclinical safety studies with the gene therapy SLS-004 and plans for future research.
Raj Mehra, PhD
Advertisement
Articles by Raj Mehra, PhD
Mehra and Subramanian discussed preclinical research with the investigational gene therapy SLS-004.
Advertisement
Latest Updated Articles
Raj Mehra, PhD, and Krishna Subramanian, PhD, on Striving For Disease-Modifying Therapies in Parkinson DiseasePublished: February 3rd 2023 | Updated:
Advertisement
Advertisement
Trending on CGTlive®
1
Autologous Stem Cell Therapy for Alzheimer Disease Advances to Phase 2 After Positive Early Findings
2
FDA Approves BMS’s Liso-Cel for R/R Marginal Zone Lymphoma
3
FasTCAR Manufactured BCMAxCD19 CAR T-cell Therapy Shows Promise for Multiple Myeloma
4
CGTLive®’s Weekly Rewind – December 5, 2025
5
